Explore Veru's Q4 2025 earnings, strategic shift to drug development, regulatory clarity, and new trials for obesity management.

Following positive efficacy and safety results from Phase 2b QUALITY study, company received FDA regulatory clarity for ...

Following positive efficacy and safety results from Phase 2b QUALITY study, company received FDA regulatory clarity for enobosarm in combination with GLP-1 RA -- -- Incremental weight loss is an accep ...

With demand for its RNA interference meds booming, Alnylam Pharmaceuticals has commenced work to soup up its flagship ...

Lung cancer is the second-most common cancer and the leading cause of cancer death in the United States. Over 80% of lung ...

The expansion will add about one-third more active manufacturing space to Alnylam's production facility in Norton, and it is ...

The City Council of Springfield voted 7-6 to reject a proposed ban on synthesized kratom, citing the city’s lack of ability ...

“The premise of this diet is that you eat (at least) 90 grams of protein, 30 grams of fiber and 50 grams of healthy fat each ...

When they stopped the visit, a balloon was found in her mouth stuffed with 11 stamp-sized pieces of paper — each soaked in a synthetic drug that thrives almost exclusively behind prison walls. It’s ...